Core Points - The company will hold its first extraordinary general meeting of shareholders in 2025 on October 23, 2025 [2][3] - The meeting will utilize the Shanghai Stock Exchange's online voting system for A-share shareholders [2][4] - The meeting will take place at Shanghai Tianxi Jiafu Putike Hotel, starting at 13:30 [3] Meeting Details - The meeting is convened by the board of directors [3] - A-share shareholders can vote both on-site and online [3] - The online voting will be available during specific trading hours on the day of the meeting [4] Voting Procedures - A-share shareholders must follow specific procedures for voting through margin trading and other accounts [5] - There are no applicable provisions for public solicitation of shareholder voting rights [6] - The voting results will be based on the first vote cast if multiple votes are submitted [11] Agenda Items - The meeting will review several proposals that have been previously disclosed [7] - Special resolutions will include proposals 1 to 5, with separate counting for small investors [8] - Certain shareholders are required to abstain from voting on specific proposals due to conflicts of interest [8][9] Attendance Information - A-share shareholders must register to attend the meeting, either online or on-site [12][15] - H-share shareholders have separate registration procedures detailed on the Hong Kong Stock Exchange website [14][19] - All expenses related to attending the meeting are to be borne by the shareholders themselves [21] Contact Information - Shareholders can contact the company's board secretary office for further inquiries [22][25]
上海复星医药(集团)股份有限公司关于召开2025年第一次临时股东会的通知